DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. USO
4. KBH
5. HTZ
6. QCOM
7. SPY
8. HON
9. SPCX
10. TTWO

Go back to DURECT Reaches Enrollment Milestone in Phase 2b AHFIRM Trial
Durect Corp (NASDAQ: DRRX) Delayed: 1.91 --0 (-0%)
Previous Close $1.91    52 Week High $2.70 
Open $1.91    52 Week Low $0.99 
Day High $1.91    P/E N/A 
Day Low $1.91    EPS $-0.22 
Volume 150,539